Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mia Wadelius

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Clinical Medicine Insights. Cardiology|January 9, 2019
Fusidic Acid: A Neglected Risk Factor for Statin-Associated MyopathyJosefine Rönnqvist, Pär Hallberg, Qun-Ying Yue, et al.
Trends in Pharmacological Sciences|February 21, 2015
Oral anticoagulation: a critique of recent advances and controversiesMunir Pirmohamed, Farhad Kamali, Ann K Daly, et al.
Pharmacoepidemiology and Drug Safety|August 15, 2023
Identification of risk factors for adverse drug reactions in a pharmacovigilance databaseSofia Attelind, Niclas Eriksson, Anders Sundström, et al.
BMC Medical Informatics and Decision Making|April 19, 2015
A Bayesian decision support tool for efficient dose individualization of warfarin in adults and childrenAnna-Karin Hamberg, Jacob Hellman, Jonny Dahlberg, et al.
Critical Reviews in Oncology/Hematology|April 13, 2025
Pharmacogenomics in pediatric oncology patients with solid tumors related to chemotherapy-induced toxicity: A systematic reviewPaula Hansson, Christopher Blacker, Hanna Uvdal, et al.
Pharmacogenomics|February 6, 2016
Novel regulatory variant detected on the VKORC1 haplotype that is associated with warfarin doseMarco Cavalli, Gang Pan, Helena Nord, et al.
The Pharmacogenomics Journal|January 18, 2020
SWEDEGENE-a Swedish nation-wide DNA sample collection for pharmacogenomic studies of serious adverse drug reactionsPär Hallberg, Qun-Ying Yue, Erik Eliasson, et al.
Nordic Journal of Psychiatry|February 27, 2004
CYP2D6 genotypes and depressive symptoms during late pregnancy and postpartumAnn Josefsson, Gunilla Sydsjö, Göran Berg, et al.
Pharmacology & Toxicology|June 6, 2003
Gene expression of cytochrome P450 1B1 and 2D6 in leukocytes in human pregnancyAnna-Britta Lind, Mia Wadelius, Elisabeth Darj, et al.
Pharmacogenomics|February 7, 2020
<i>MTHFR</i>, <i>TYMS</i> and <i>SLCO1B1</i> polymorphisms and adverse liver effects of methotrexate in rheumatoid arthritisJohanna Karlsson Sundbaum, Eva Baecklund, Niclas Eriksson, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Clinical Medicine Insights. Cardiology|January 9, 2019
Fusidic Acid: A Neglected Risk Factor for Statin-Associated MyopathyJosefine Rönnqvist, Pär Hallberg, Qun-Ying Yue, et al.
Trends in Pharmacological Sciences|February 21, 2015
Oral anticoagulation: a critique of recent advances and controversiesMunir Pirmohamed, Farhad Kamali, Ann K Daly, et al.
Pharmacoepidemiology and Drug Safety|August 15, 2023
Identification of risk factors for adverse drug reactions in a pharmacovigilance databaseSofia Attelind, Niclas Eriksson, Anders Sundström, et al.
BMC Medical Informatics and Decision Making|April 19, 2015
A Bayesian decision support tool for efficient dose individualization of warfarin in adults and childrenAnna-Karin Hamberg, Jacob Hellman, Jonny Dahlberg, et al.
Critical Reviews in Oncology/Hematology|April 13, 2025
Pharmacogenomics in pediatric oncology patients with solid tumors related to chemotherapy-induced toxicity: A systematic reviewPaula Hansson, Christopher Blacker, Hanna Uvdal, et al.
Pharmacogenomics|February 6, 2016
Novel regulatory variant detected on the VKORC1 haplotype that is associated with warfarin doseMarco Cavalli, Gang Pan, Helena Nord, et al.
The Pharmacogenomics Journal|January 18, 2020
SWEDEGENE-a Swedish nation-wide DNA sample collection for pharmacogenomic studies of serious adverse drug reactionsPär Hallberg, Qun-Ying Yue, Erik Eliasson, et al.
Nordic Journal of Psychiatry|February 27, 2004
CYP2D6 genotypes and depressive symptoms during late pregnancy and postpartumAnn Josefsson, Gunilla Sydsjö, Göran Berg, et al.
Pharmacology & Toxicology|June 6, 2003
Gene expression of cytochrome P450 1B1 and 2D6 in leukocytes in human pregnancyAnna-Britta Lind, Mia Wadelius, Elisabeth Darj, et al.
Pharmacogenomics|February 7, 2020
<i>MTHFR</i>, <i>TYMS</i> and <i>SLCO1B1</i> polymorphisms and adverse liver effects of methotrexate in rheumatoid arthritisJohanna Karlsson Sundbaum, Eva Baecklund, Niclas Eriksson, et al.
Pageof 10